双刚性纳米粒子用于在中风中分区特定的药物输送
Hui Liu1, Juanjuan Zheng1, Yaosheng Li1
1State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P. R. China.
Nature communications
|March 13, 2026
概括
这项研究引入了用于向性缺血性中风治疗的双刚性纳米粒子. 硬的纳米颗粒向外围炎症,而软的纳米颗粒保护大脑,提供了一种新的精确纳米医学方法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 神经科学是一个神经科学.
背景情况:
- 缺血性中风涉及外周免疫系统和中枢神经系统的复杂炎症.
- 传统的治疗方法往往无法有效地解决这种双隔间病理.
- 需要针对性疗法,可以调节系统和中枢神经系统的反应.
研究的目的:
- 开发一个空间分层的药物输送系统,使用双刚性纳米粒子进行向性缺血性中风干预.
- 为了研究硬度依赖的纳米粒子生物分布的机制.
- 通过单次注射来证明外周-中心协同治疗效应.
主要方法:
- 制造双刚性纳米粒子 (NP).
- 基于硬度的NP生物分布的评估.
- 传递抗炎药物到周边免疫细胞和神经保护剂到大脑.
- 涉及膜能量和蛋白质吸附的机制研究.
主要成果:
- 硬的NP优先准外围免疫细胞,减少全身炎症.
- 软NP成功地透到大脑中,提供神经保护剂.
- 差异分布归因于NP硬度介导的与生物成分的相互作用.
- 在单次使用时观察到协同效应的治疗效应.
结论:
- 双刚性纳米颗粒使得缺血性中风的隔间特定药物输送成为可能.
- 这种机器引导的纳米医学策略为治疗多个病房的疾病提供了一个范例.
- 这种方法在精确治疗干预方面具有重大潜力.
更多相关视频
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
16.5K
14:53Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
Published on: June 26, 2020
11.2K
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
Modified-Release Drug Delivery Systems: Stimuli-Activated
73
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
73
Modified-Release Drug Delivery Systems: Site-Targeted
70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
